EPISODE · Oct 28, 2025 · 2 MIN
ACT Brief: AI Expands Global Site Leadership as Ozempic Shows Potential to Reverse Biological Age
from Applied Clinical Trials · host Applied Clinical Trials
In today’s ACT Brief, we examine how artificial intelligence is helping uncover site leaders in underserved regions to strengthen trial diversity—and explore new research suggesting Ozempic may reduce biological age by more than three years.
Embed this episode
Ready to play
ACT Brief: AI Expands Global Site Leadership as Ozempic Shows Potential to Reverse Biological Age
0:00
2:18
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Applied Clinical Trials?
This episode is 2 minutes long.
When was this Applied Clinical Trials episode published?
This episode was published on October 28, 2025.
Can I download this Applied Clinical Trials episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!